RSVVW'21 - AN ONLINE VIRTUAL EVENT
|
We are excited to announce that we will host our 6th conference “RSVVW’21 – A Global Conference on Novel RSV Preventive and Therapeutic Interventions” as an online virtual conference on 10 – 12 November 2021. The registration and call for abstracts will open in June! You can find the latest updates regarding the conference on our website, so stay tuned.
|
News
WHEN COVID-19 CASES DECLINE OTHER DISEASES REAPPEAR: RSV OUTBREAK IN SOUTH-EAST QUEENSLAND
During the COVID-19 pandemic, other respiratory viruses such as influenza and RSV have decreased, assumingly due to the related public health measurements. However, as social distancing regulations are decreasing, the usual illnesses may reappear in higher rates than before. In south-east ... Read more |
Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19"Pfizer and BioNTech SE announced an advance purchase agreement with COVAX for up to 40 million doses of the Pfizer-BioNTech COVID-19 Vaccine. The doses will be delivered throughout 2021. COVAX is a global initiative coordinated by the Global Alliance for Vaccines and Immunization (GAVI) ..." Read more |
Paper of the month
- May 2021 -
How to use potential RSV preventive interventions wisely? A modelling study on seasonal-approaches of maternal vaccination and passive immunization As soon as the temperature goes down by the end of summer and the beginning of fall, viruses are lurking around the corner. RSV is also such a virus, which has a clear seasonality in most countries. Maternal ... |
- April 2021 -
Sustainable response to DS-Cav1 in healthy volunteers The Vaccine Research Center of NIH published a randomized, open-label, dose-escalation phase 1 clinical trial of the DS-Cav1 stabilized pre-F subunit vaccine. 95 healthy adults were... |
- March 2021 -
Outpatient burden of RSV infection in newborns RSV is the number one cause of hospitalization for acute lower respiratory tract infection in infants. Moreover, RSV affects an even bigger group of non-hospitalized children. Thomas and his ... |
On 12- 14 November 2019 ReSViNET Foundation heldt its 5th conference: “RSVVW 2019 - A Global Conference on Novel RSV Preventive and Therapeutic Interventions" in Accra, Ghana. We look back on a successful, exciting and inspiring meeting. Our special thanks to our sponsors to make this event possible and our chairs and scientific advisory board. Last but not least we thank all the speakers and participants for their contributions. |
AWARENESS OF RSV AS A GLOBAL HEALTH PROBLEM IS LACKING
|
To raise and spread awareness, we have launched a ‘RSV Mortality Awareness’ campaign at the start of the RSVVW2019 conference on November 12, by sharing a personal video entitled “Why we should all know about RSV” about Simone van Wyck, a mother who lost her son due to RSV. The RSV awareness video was produced in collaboration with the Bill & Melinda Gates Foundation.
|
|
ABOUT RESVINET FOUNDATIONRSV (Respiratory Syncytial Virus) infection is the second most important cause of death during infancy, especially in developing countries. |
ReSViNET Foundation is certified by NGOsource as equivalent to a U.S. public charity!
|
|
We would like to express our sincere condolences to Neeltjes' family for their loss. Jan. 2020.
Neeltje from The Netherlands, 99 years old, participant of the RESCEU Older adults study. RSV is an important cause of pneumonia in older adults. Awareness of RSV in older adults is almost absent. Every year about 3-6% of all older adults are infected with RSV. Course of disease is most severe on older adults with severe underlying disease such as heart failure or COPD. |
ReSViNET Global partners
